Mariah Baltezegar

MBA, Executive Director, Head of PPA Virtual Trials, Real-World Evidence

Mariah is a senior leader within the Peri- and Post-Approval Studies (PPAS) group, responsible for the performance, growth and development of virtual trial approaches and associated, integrated solutions. For 20 years she has been working in various clinical research capacities, including a proven 17-year history in operations and business procurement.  She has established herself as a results-oriented, motivated leader of global, interdisciplinary teams to develop innovative solutions to meet client needs. Mariah also has 13 years of experience working in various capacities in the complex space of rare disease development.

While working in the rare disease space Mariah has developed a unique perspective on the complicated choreography needed to be successful in rare disease development, including minimizing patient and site burden, integration of patient advocacy groups in the development process, managing advocacy groups, the importance of the patient, site and sponsor relationship, and developing focused strategies for program and study success.

Prior to her role in PPAS virtualization, Mariah served as a customer relationship executive (CRE) at Syneos Health focused on rare diseases. In this role, she was responsible for oversight of business aspects of clinical operations, project management and business development for the rare disease therapeutic area and successfully increased profitability as well as procured an early development partnership with a key partner.  As the co-lead of the Rare Disease Consortium, she collaborated across the organization to develop innovative strategies to address the needs of rare disease pharma and biotech companies in both development and commercialization

Mariah began her clinical research career at the site as a clinical research coordinator where she gained experience directly working to recruit patients, perform study procedures and manage their study participation and retention.  From there, Mariah moved to begin her CRO career at Evidera’s parent company, PPD, spending nine years working up through all levels of clinical operations gaining intimate understanding of patient, site and sponsor needs for successful study conduct. Following her time in operations, she moved to the commercial team at PPD where she successfully led teams in development of patient-centric strategies to meet client development objectives in rare diseases for six years.

Mariah completed her Master of Business Administration degree at the University of North Carolina, Wilmington. She also holds a bachelor’s degree in psychology with a minor in statistics from Winona State University.